Table 2 Median survival data (months) of metastatic angiosarcomas
Variable | OS | CSS | ||
|---|---|---|---|---|
Estimate ± SE | 95%CI | Estimate ± SE | 95%CI | |
Age at diagnosis (years) | ||||
≤ 60 | 5.0 ± 0.9 | 3.323–6.677 | 5.0 ± 0.9 | 3.228–6.772 |
> 60 | 2.0 ± 0.4 | 1.168–2.832 | 2.0 ± 0.5 | 1.005–2.995 |
Gender | ||||
Female | 4.0 ± 0.7 | 2.575–5.425 | 4.0 ± 1.0 | 2.100–5.900 |
Male | 3.0 ± 0.6 | 1.795–4.205 | 3.0 ± 0.6 | 1.845–4.155 |
Race | ||||
White | 3.0 ± 0.5 | 2.063–3.937 | 3.0 ± 0.5 | 1.972–4.028 |
Black | 4.0 ± 1.7 | 0.757–7.243 | 4.0 ± 1.4 | 1.309–6.691 |
Other | 6.0 ± 4.2 | 0.000–14.305 | 6.0 ± 2.6 | 0.842–11.158 |
Year of diagnosis | ||||
2010–2012 | 4.0 ± 1.0 | 2.068–5.932 | 3.0 ± 0.9 | 1.280–4.720 |
2013–2014 | 4.0 ± 0.8 | 2.403–5.597 | 3.0 ± 0.9 | 1.272–4.728 |
2015–2016 | 3.0 ± 0.6 | 1.844–4.156 | 3.0 ± 1.0 | 1.124–4.876 |
Grade | ||||
I + II | N/A | N/A | 3.0 ± 0.6 | 1.863–4.137 |
III | 4.0 ± 1.0 | 2.137–5.863 | 4.0 ± 1.5 | 0.986–7.014 |
IV | 4.0 ± 0.7 | 2.534–5.466 | 4.0 ± 0.7 | 2.588–5.412 |
NO. of metastatic sites | ||||
1 | 3.0 ± 0.6 | 1.789–4.211 | 4.0 ± 0.9 | 2.162–5.838 |
≥ 2 | 3.0 ± 0.7 | 1.589–4.411 | 3.0 ± 0.7 | 1.629–4.371 |
Size (cm) | ||||
≤ 10 | 6.0 ± 1.1 | 3.887–8.113 | 9.0 ± 1.9 | 5.337–12.663 |
> 10 | 2.0 ± 0.7 | 0.701–3.299 | 3.0 ± 0.6 | 1.840–4.160 |
Treatment | ||||
Chemotherapy | ||||
Yes | 8.0 ± 1.0 | 6.083–9.917 | 8.0 ± 1.3 | 5.444–10.556 |
No | 1.0 ± 0.2 | 0.692–1.308 | 1.0 ± 0.2 | 0.636–1.364 |
RT | ||||
Yes | 7.0 ± 1.6 | 3.875–10.125 | 6.0 ± 1.6 | 2.870–9.130 |
No | 3.0 ± 0.4 | 2.202–3.798 | 3.0 ± 0.4 | 2.200–3.800 |
ST | ||||
Yes | 3.0 ± 0.5 | 2.022–3.978 | 3.0 ± 0.6 | 1.876–4.124 |
No | 3.0 ± 0.7 | 1.710–4.290 | 3.0 ± 0.7 | 1.621–4.379 |
Overall | 3.0 ± 0.5 | 2.078–3.922 | 3.0 ± 0.5 | 1.979–4.021 |